GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monogram Orthopaedics Inc (NAS:MGRM) » Definitions » EV-to-EBIT

Monogram Orthopaedics (Monogram Orthopaedics) EV-to-EBIT : -2.73 (As of May. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Monogram Orthopaedics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Monogram Orthopaedics's Enterprise Value is $47.06 Mil. Monogram Orthopaedics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-17.27 Mil. Therefore, Monogram Orthopaedics's EV-to-EBIT for today is -2.73.

The historical rank and industry rank for Monogram Orthopaedics's EV-to-EBIT or its related term are showing as below:

MGRM' s EV-to-EBIT Range Over the Past 10 Years
Min: -5.98   Med: -3.96   Max: -2.62
Current: -2.77

During the past 7 years, the highest EV-to-EBIT of Monogram Orthopaedics was -2.62. The lowest was -5.98. And the median was -3.96.

MGRM's EV-to-EBIT is ranked worse than
100% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 20.465 vs MGRM: -2.77

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Monogram Orthopaedics's Enterprise Value for the quarter that ended in Dec. 2023 was $94.71 Mil. Monogram Orthopaedics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-17.27 Mil. Monogram Orthopaedics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -18.23%.


Monogram Orthopaedics EV-to-EBIT Historical Data

The historical data trend for Monogram Orthopaedics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monogram Orthopaedics EV-to-EBIT Chart

Monogram Orthopaedics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - - - -5.48

Monogram Orthopaedics Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -6.94 -3.79 -5.48

Competitive Comparison of Monogram Orthopaedics's EV-to-EBIT

For the Medical Devices subindustry, Monogram Orthopaedics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Monogram Orthopaedics's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Monogram Orthopaedics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Monogram Orthopaedics's EV-to-EBIT falls into.



Monogram Orthopaedics EV-to-EBIT Calculation

Monogram Orthopaedics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=47.057/-17.268
=-2.73

Monogram Orthopaedics's current Enterprise Value is $47.06 Mil.
Monogram Orthopaedics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monogram Orthopaedics  (NAS:MGRM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Monogram Orthopaedics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-17.268/94.707096
=-18.23 %

Monogram Orthopaedics's Enterprise Value for the quarter that ended in Dec. 2023 was $94.71 Mil.
Monogram Orthopaedics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monogram Orthopaedics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Monogram Orthopaedics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Monogram Orthopaedics (Monogram Orthopaedics) Business Description

Traded in Other Exchanges
Address
3913 Todd Lane, Suite 307, Austin, TX, USA, 78744
Monogram Orthopaedics Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
Executives
Paul H Riss director
Noel Knape officer: Chief Financial Officer 3913 TODD LANE, AUSTIN TX 78744
Benjamin Sexson director, 10 percent owner, officer: Chief Executive Officer 3913 TODD LANE, AUSTIN TX 78744
Noel Goddard director 3913 TODD LANE, AUSTIN TX 78744
Kamran Shamaei officer: Chief Technology Officer 3913 TODD LANE, AUSTIN TX 78744
Douglas Unis director 3913 TODD LANE, AUSTIN TX 78744